GLA
IDYA icon

Great Lakes Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Great Lakes Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.27M Sell
87,747
-53,301
-38% -$1.63M 0.02% 330
2026
Q1 		$4.7M Sell
141,048
-8,945
-6% -$300K 0.04% 238
2025
Q4 		$5.19M Buy
+149,993
New +$4.78M 0.04% 229

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Great Lakes Advisors's IDYA Position: Q2 2026 in Review

Great Lakes Advisors reduced its IDEAYA Biosciences (IDYA) stake by 38% in Q2 2026, selling an estimated $1.63M and leaving 87,747 shares worth $3.27M. The position accounts for 0.02% of the portfolio, ranked #330.

Great Lakes Advisors first reported a position in IDYA in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.19M in Q4 2025. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Great Lakes Advisors held 87,747 shares of IDEAYA Biosciences worth $3.27M as of Q2 2026.
  • Great Lakes Advisors sold 53,301 IDEAYA Biosciences shares in Q2 2026, an estimated $1.63M.
  • IDEAYA Biosciences made up 0.02% of Great Lakes Advisors's portfolio in Q2 2026, its #330 holding.
  • Great Lakes Advisors first reported a position in IDEAYA Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Great Lakes Advisors's IDEAYA Biosciences position peaked at $5.19M in Q4 2025.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.